“Open-Label Study (ARIDO) Evaluating Long-Term Safety of Topical Glycopyrronium Tosylate (GT) in Patients with Primary Axillary Hyperhydrosis”, J of Skin, vol. 2, no. S1, p. S40, Feb. 2018, doi: 10.25251/skin.2.supp.40.